Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 11/20 | 0.54 |
| ▸ | GFER | P55789 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | MIF | P14174 | 1/20 | 0.54 |
| ▸ | CASP3 | P42574 | 1/20 | 0.52 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.52 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.52 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.52 |
| ▸ | BACE1 | P56817 | 3/20 | 0.52 |
| ▸ | BACE2 | Q9Y5Z0 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.51 |
| ▸ | NPC1 | O15118 | 9/20 | 0.51 |
| ▸ | PKM | P14618 | 4/20 | 0.51 |
| ▸ | POLB | P06746 | 3/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19726974 | 0.96 | RAB9A (0.58) | RAB9AGFERMEN1KMT2AGAA | |
| SCHEMBL13454289 | 0.93 | RAB9A (0.61) | RAB9AGFERMEN1KMT2AGAA | |
| SCHEMBL973176 | 0.92 | RAB9A (0.57) | RAB9AGFERMEN1KMT2AGAA | |
| SCHEMBL13454262 | 0.92 | RAB9A (0.57) | RAB9AGFERMEN1KMT2AGAA | |
| SCHEMBL13454306 | 0.91 | RAB9A (0.56) | RAB9AGFERMEN1KMT2AGAA | |
| SCHEMBL971054 | 0.91 | RAB9A (0.56) | RAB9AGFERMEN1KMT2AGAA | |
| SCHEMBL13454266 | 0.91 | RAB9A (0.56) | RAB9AGFERMEN1KMT2AGAA | |
| SCHEMBL18288731 | 0.88 | RAB9A (0.56) | RAB9AGFERMEN1KMT2AGAA | |
| SCHEMBL18288729 | 0.88 | RAB9A (0.56) | RAB9AGFERMEN1KMT2AGAA | |
| SCHEMBL11885961 | 0.88 | RAB9A (0.46) | RAB9AGFERMEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10297760-B2 | Organic electroluminescent element, compound and material for organic electroluminescent element, used in the same, and light emitting device, display device and illumination device, using the element | UDC IRELAND LIMITED (IE) | 2019-05-21 | — | — | US | disclosed |
| US-20180102483-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND AND MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, USED IN THE SAME, AND LIGHT EMITTING DEVICE, DISPLAY DEVICE AND ILLUMINATION DEVICE, USING THE ELEMENT | UDC IRELAND LTD (IE) | 2018-04-12 | — | — | US | disclosed |
| US-20180102483-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND AND MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, USED IN THE SAME, AND LIGHT EMITTING DEVICE, DISPLAY DEVICE AND ILLUMINATION DEVICE, USING THE ELEMENT | UDC IRELAND LTD (IE) | 2018-04-12 | — | — | US | disclosed |
| US-9812650-B2 | Organic electroluminescent element, compound and material for organic electroluminescent element, used in the same, and light emitting device, display device and illumination device, using the element | UDC IRELAND LIMITED (IE) | 2017-11-07 | — | — | US | disclosed |
| US-9812650-B2 | Organic electroluminescent element, compound and material for organic electroluminescent element, used in the same, and light emitting device, display device and illumination device, using the element | UDC IRELAND LIMITED (IE) | 2017-11-07 | — | — | US | disclosed |
| US-9608207-B2 | Organic electroluminescence element | UDC IRELAND LIMITED (IE) | 2017-03-28 | — | — | US | disclosed |
| US-9608207-B2 | Organic electroluminescence element | UDC IRELAND LIMITED (IE) | 2017-03-28 | — | — | US | disclosed |
| US-20150076462-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND AND MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, USED IN THE SAME, AND LIGHT EMITTING DEVICE, DISPLAY DEVICE AND ILLUMINATION DEVICE, USING THE ELEMENT | UDC IRELAND LIMITED (IE) | 2015-03-19 | — | — | US | disclosed |
| US-20150076462-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND AND MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, USED IN THE SAME, AND LIGHT EMITTING DEVICE, DISPLAY DEVICE AND ILLUMINATION DEVICE, USING THE ELEMENT | UDC IRELAND LIMITED (IE) | 2015-03-19 | — | — | US | disclosed |
| US-20140299851-A1 | Organic Electroluminescence Element | UDC IRELAND LIMITED (IE) | 2014-10-09 | — | — | US | disclosed |
| US-20140299851-A1 | Organic Electroluminescence Element | UDC IRELAND LIMITED (IE) | 2014-10-09 | — | — | US | disclosed |
| US-7867629-B2 | Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10297760-B2 | Organic electroluminescent element, compound and material for organic electroluminescent element, used in the same, and light emitting device, display device and illumination device, using the element | RPS10, RPS20, RPS19 | RAB9A 851/4885GFER 3513/4885MEN1 2513/4885 |
| US-20180102483-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND AND MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, USED IN THE SAME, AND LIGHT EMITTING DEVICE, DISPLAY DEVICE AND ILLUMINATION DEVICE, USING THE ELEMENT | RPS10, RPS20, RPS19 | RAB9A 851/4885GFER 3513/4885MEN1 2513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.